| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Halobetasol propionate preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Beclometasone-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Paramethasone-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Triamcinolone diacetate preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing fluocinonide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Betamethasone acetate preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Glucocorticoid systemic preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing methylprednisolone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing betamethasone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing flumetasone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Beclomethasone dipropionate nasal preparation (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing hydrocortamate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Beclomethasone dipropionate preparation (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing fluprednisolone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing dexamethasone in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing flunisolide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Triamcinolone dental paste |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Prednisolone-containing product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dexamethasone sodium phosphate (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing prednisolone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing dexamethasone in nasal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Paramethasone acetate preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Triamcinolone-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Betamethasone sodium phosphate preparation (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Meprednisone preparation (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dichlorisone-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing fluorometholone in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Flunisolide nasal preparation (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing betamethasone valerate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Flurandrenolide preparation (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Triamcinolone acetonide (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing dexamethasone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing desoximetasone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dexamethasone-21-isonicotinate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Methylprednisolone acetate 80mg/mL injection suspension 1mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely fluocinonide 1 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Prednisolone acetate + sulfacetamide sodium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Clobetasol propionate emollient 0.05% cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing fluorometholone and tobramycin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Tobramycin 0.3%/fluorometholone 0.1% ophthalmic suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Triamcinolone acetonide 50 microgram/actuation nasal spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Prednisolone [for preparations see rectal prednisolone] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Rectal prednisolone |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Beclomethasone dipropionate [respiratory use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Beclomethasone dipropionate [respiratory use 2] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dexamethasone [endocrine use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Methylprednisolone [endocrine use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Prednisolone [endocrine use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Triamcinolone [endocrine use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Kenalog 80mg/2mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dexamethasone 250 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely dexamethasone 1.5 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely dexamethasone 6 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dexamethasone sodium phosphate [musculoskeletal use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Methylprednisolone acetate [musculoskeletal use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Prednisolone acetate [musculoskeletal use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Prednisolone sod phos [musc-sk] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Triamcinolone acetonide [musculoskeletal use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Betamethasone sodium phosphate [eye] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dexamethasone [eye] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dexamethasone compound eye ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dexamethasone eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Prednisolone sod phos [eye] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Prednisolone eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Prednisolone acetate [eye] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Betamethasone sodium phosphate [ear] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Prednisolone sodium phosphate [ear] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Beclomethasone dipropionate [nose] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Betamethasone sodium phosphate [nose] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Triamcinolone acetate [nose] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Topical form corticosteroids |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Beclomethasone diprop [skin] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Betamethasone + antimicrobials |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Stiedex LPN oily cream 15g |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Triamcinolone acetonide [skin] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Stiedex LPN oily cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dexamethasone 1 mg/mL and tobramycin 3 mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Calcipotriol+betamethasone 50micrograms/500micrograms/g ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing dexamethasone and tobramycin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Flunisolide 250mcg/inh inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Halobetasol propionate 0.05% cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Halobetasol propionate 0.05% ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Fluorometholone acetate 0.1% suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Prednisolone acetate 1% |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dexamethasone acetate 8 mg/mL suspension for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Prednisolone acetate 10 mg/mL eye suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely fluorometholone 1 milligram/1 milliliter conventional release eye suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Triamcinolone diacetate 40 mg/mL suspension for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Methylprednisolone sodium su 125mg/2mL powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Methylprednisolone sodium su 40mg/mL powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Betamethasone valerate 0.12% |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Betamethasone valerate 0.12% aerosol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Loteprednol etabonate 2 mg/mL eye suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely loteprednol etabonate 5 milligram/1 milliliter conventional release eye suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Amcinonide 1 mg/mL cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Diflorasone diacetate 0.5mg ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely diflorasone diacetate 500 microgram/1 milliliter conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Beclomethasone dipropionate 42mcg aerosol (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Flunisolide 250mcg/inh |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Flunisolide 0.025% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Flurandrenolide 4mcg/sq/cm tape |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.4-SNAPSHOT
|
FHIR Version n/a
User: [n/a]